Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 44, Pages 12532-12537
Publisher
Proceedings of the National Academy of Sciences
Online
2016-10-19
DOI
10.1073/pnas.1610258113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
- (2015) G. Masi et al. ANNALS OF ONCOLOGY
- Intertwined regulation of angiogenesis and immunity by myeloid cells
- (2015) Lee B. Rivera et al. TRENDS IN IMMUNOLOGY
- Therapeutic Vaccination with TNF-Kinoid in TNF Antagonist-Resistant Rheumatoid Arthritis: A Phase II Randomized, Controlled Clinical Trial
- (2014) Patrick Durez et al. PLoS One
- Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial
- (2014) J.V. Gavilondo et al. VACCINE
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- Total Chemical Synthesis of Biologically Active Vascular Endothelial Growth Factor
- (2011) Kalyaneswar Mandal et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Enhancement of T-cell-Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer
- (2011) R. P. M. Dings et al. CLINICAL CANCER RESEARCH
- Tying the knot: The cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines
- (2011) Shalini Iyer et al. FEBS Journal
- Anti-angiogenesis immunotherapy
- (2011) Jonathan D. Schoenfeld et al. Human vaccines & immunotherapeutics
- Engineered Conformation-dependent VEGF Peptide Mimics Are Effective in Inhibiting VEGF Signaling Pathways
- (2011) Daniele Vicari et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacological and toxicological assessment of a potential GnRH vaccine in young-adult male pigs
- (2011) J.A. Turkstra et al. VACCINE
- Development of a highly immunogenic recombinant candidate vaccine against human chorionic gonadotropin
- (2011) Shilpi Purswani et al. VACCINE
- Synthesis and Immune Response of Non-native Isomers of Vascular Endothelial Growth Factor
- (2010) Chuantao Jiang et al. BIOCHEMISTRY
- Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy
- (2010) A. Bagri et al. CLINICAL CANCER RESEARCH
- Immunization with synthetic VEGF peptides in ovarian cancer
- (2010) Bing Wang et al. GYNECOLOGIC ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started